Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants. (Q38253060)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243342%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

review article

1 reference

title

Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243342%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243342%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Eugenio Barone

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243342%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Marzia Perluigi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243342%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

D Allan Butterfield

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243342%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

22 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243342%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

17 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243342%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243342%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

19-40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243342%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243342%20AND%20SRC:MED&resulttype=core&format=json

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

17 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Role of oxidative stress in the progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Oxidative stress hypothesis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Decreased plasma antioxidants in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Alzheimer Disease and Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Antioxidant therapies for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Oxidative stress and β-amyloid protein in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Mitochondrial- and endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Glial cell dysregulation: a new perspective on Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Age-dependent cytokine responses: trimethyltin hippocampal injury in wild-type, APOE knockout, and APOE4 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Immune-mediated CNS damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Glia and their cytokines in progression of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Functional aspects of redox control during neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Evidence of increased oxidative damage in subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Mass spectrometry and redox proteomics: applications in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Nuclear and mitochondrial DNA oxidation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

DNA oxidation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Serum nitrosative stress levels are increased in Alzheimer disease but not in vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Lymphocyte mitochondria: toward identification of peripheral biomarkers in the progression of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

In vivo modulation of rodent glutathione and its role in peroxynitrite-induced neocortical synaptosomal membrane protein damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Protective effect of N-acetyl-L-cysteine on amyloid beta-peptide-induced learning and memory deficits in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Nutritional approaches to modulate oxidative stress in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Different protection of K252a and N-acetyl-L-cysteine against amyloid-beta peptide-induced cortical neuron apoptosis involving inhibition of MLK3-MKK7-JNK3 signal cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

N-acetylcysteine prevents beta-amyloid toxicity by a stimulatory effect on p35/cyclin-dependent kinase 5 activity in cultured cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Proteomic analysis of brain proteins in APP/PS-1 human double mutant knock-in mice with increasing amyloid β-peptide deposition: insights into the effects of in vivo treatment with N-acetylcysteine as a potential therapeutic intervention in mild cog

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Amelioration of social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit by N-acetylcysteine in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Up-regulation of β-amyloidogenesis in neuron-like human cells by both 24- and 27-hydroxycholesterol: protective effect of N-acetyl-cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Protective effect of the xanthate, D609, on Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress in primary neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Protective effect of D609 against amyloid-beta1-42-induced oxidative modification of neuronal proteins: redox proteomics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

In vivo protection of synaptosomes from oxidative stress mediated by Fe2+/H2O2 or 2,2-azobis-(2-amidinopropane) dihydrochloride by the glutathione mimetic tricyclodecan-9-yl-xanthogenate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Protection against amyloid beta-peptide (1–42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: Implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid beta-peptide and other oxidative stressors: relevance to Alzheimer's disease and other ox

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Plasma selenium over time and cognitive decline in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Selenium and human health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Organoselenium (Sel-Plex diet) decreases amyloid burden and RNA and DNA oxidative damage in APP/PS1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Selenium attenuates A beta production and A beta-induced neuronal death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Treatment of Alzheimer's disease with a cholinesterase inhibitor combined with antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Organoselenium improves memory decline in mice: involvement of acetylcholinesterase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Neuroprotector effect of p,p'-methoxyl-diphenyl diselenide in a model of sporadic dementia of Alzheimer's type in mice: contribution of antioxidant mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Therapeutic effect of organoselenium dietary supplementation in a sporadic dementia of Alzheimer's type model in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Souvenaid®: a new approach to management of early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Nutritional approaches in the risk reduction and management of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Practice effects in a longitudinal, multi-center Alzheimer's disease prevention clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Vitamin E in aging, dementia, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Role of tocopherols in the protection of biological systems against oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Vitamin E: protective role of a Janus molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Nutritional approaches to combat oxidative stress in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Antioxidant vitamin intake and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Dietary intake of antioxidants and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Effect of one-year vitamin C- and E-supplementation on cerebrospinal fluid oxidation parameters and clinical course in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Delivery of orally supplemented alpha-tocotrienol to vital organs of rats and tocopherol-transport protein deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Caffeic acid derivatives in artichoke extract are metabolised to phenolic acids in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Ferulic acid and its therapeutic potential as a hormetin for age-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Ferulic acid: pharmacological and toxicological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Antioxidant properties of ferulic acid and its related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Ferulic Acid: therapeutic potential through its antioxidant property.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Differential distribution of ferulic acid to the major plasma constituents in relation to its potential as an antioxidant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Antioxidant effect of ferulic acid in isolated membranes and intact cells: synergistic interactions with alpha-tocopherol, beta-carotene, and ascorbic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Protective effects of ferulic acid in amyloid precursor protein plus presenilin-1 transgenic mouse model of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Chemistry and biology of vitamin E

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

The protective role of carotenoids against 7-keto-cholesterol formation in solution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Curcumin in clinical practice: myth or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Curcumin and Alzheimer disease: this marriage is not to be performed

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Therapeutic use of tea derivatives: all that glitters is not gold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Natural substances and Alzheimer's disease: from preclinical studies to evidence based medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Ferulic acid is a nutraceutical β-secretase modulator that improves behavioral impairment and alzheimer-like pathology in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Ferulic acid ethyl ester protects neurons against amyloid beta- peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Alkyl esters of hydroxycinnamic acids with improved antioxidant activity and lipophilicity protect PC12 cells against oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Stearyl ferulate-based solid lipid nanoparticles for the encapsulation and stabilization of beta-carotene and alpha-tocopherol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

A novel dextran hydrogel linking trans-ferulic acid for the stabilization and transdermal delivery of vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Design and synthesis of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Tacrine-6-ferulic acid, a novel multifunctional dimer, inhibits amyloid-β-mediated Alzheimer's disease-associated pathogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Chronic 1alpha,25-(OH)2 vitamin D3 treatment reduces Ca2+ -mediated hippocampal biomarkers of aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

21 January 2018

Vitamin D and the brain.

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Vitamin D deficiency and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Low serum 25-hydroxyvitamin D concentrations are associated with greater all-cause mortality in older community-dwelling women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: Mitochondrial dysfunction, glutamate dysregulation and impaired protein synthe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Serum 25-hydroxyvitamin D concentration and cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Vitamin D and risk of cognitive decline in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

1,25-dihydroxyvitamin D3 regulates the synthesis of gamma-glutamyl transpeptidase and glutathione levels in rat primary astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Vitamin D-binding protein interacts with Aβ and suppresses Aβ-mediated pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Vitamin D insufficiency and mild cognitive impairment: cross-sectional association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: implications for low vitamin D-dependent age-related cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Alzheimer's disease--input of vitamin D with mEmantine assay (AD-IDEA trial): study protocol for a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Melatonin and mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

High levels of melatonin in the seeds of edible plants: possible function in germ tissue protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Melatonin: an antioxidant in edible plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Regulation of antioxidant enzymes: a significant role for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Beneficial effects of melatonin in experimental models of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Melatonin prevents amyloid protofibrillar induced oxidative imbalance and biogenic amine catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Constant illumination induces Alzheimer-like damages with endoplasmic reticulum involvement and the protection of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Melatonin ameliorates Alzheimer-like pathological changes and spatial memory retention impairment induced by calyculin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Melatonin plus physical exercise are highly neuroprotective in the 3xTg-AD mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Mitochondria: a therapeutic target in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Abnormal mitochondrial dynamics--a novel therapeutic target for Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Brain metabolic dysfunction at the core of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Targeting antioxidants to mitochondria by conjugation to lipophilic cations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Targeting antioxidants to mitochondria: a new therapeutic direction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

The mitochondria-targeted antioxidant MitoQ extends lifespan and improves healthspan of a transgenic Caenorhabditis elegans model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Oxidative stress in Alzheimer disease: a possibility for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Oxidative modification of lipoic acid by HNE in Alzheimer disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Mitochondria-targeted peptide antioxidants: novel neuroprotective agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Development of mitochondria-targeted aromatic-cationic peptides for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Mitochondrial Targeting with Antioxidant Peptide SS-31 Prevents Mitochondrial Depolarization, Reduces Islet Cell Apoptosis, Increases Islet Cell Yield, and Improves Posttransplantation Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Assessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer's disease mice: Implications for impaired mitochondrial biogenesis and synaptic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Toxicity of neurons treated with herbicides and neuroprotection by mitochondria-targeted antioxidant SS31.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Tocopherols and tocotrienols plasma levels are associated with cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Trans-ferulic acid-based solid lipid nanoparticles and their antioxidant effect in rat brain microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853

Design and Synthesis of Cellulose Derivatives with Antioxidant Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.955853